Facility type
|
Community cancer program
|
1.26
|
1.07–1.49
|
0.01
|
Comprehensive community cancer program
|
1.20
|
1.09–1.32
|
< 0.001
|
Academic/research program
|
REF
| | |
Other
|
1.13
|
0.95–1.33
|
0.16
|
Age category (years)
|
< 40
|
REF
| | |
40–49
|
0.48
|
0.38–0.61
|
< 0.001
|
50–59
|
0.34
|
0.27–0.43
|
< 0.001
|
60–69
|
0.20
|
0.16–0.26
|
< 0.001
|
70–79
|
0.10
|
0.07–0.14
|
< 0.001
|
80+
|
0.07
|
0.03–0.16
|
< 0.001
|
Race/ethnicity
|
Non-Hispanic White
|
REF
| | |
Non-Hispanic Black
|
1.10
|
0.94–1.40
|
0.26
|
Hispanic
|
1.04
|
0.85–1.27
|
0.73
|
Non-Hispanic Asian/Pacific
|
0.94
|
0.76–1.17
|
0.60
|
Other
|
1.15
|
0.94–1.40
|
0.19
|
Primary payer
|
Not insured
|
1.09
|
0.80–1.48
|
0.59
|
Private insurance
|
REF
| | |
Medicaid
|
0.91
|
0.76–1.09
|
0.30
|
Medicare
|
0.73
|
0.63–0.85
|
< 0.001
|
Other
|
0.79
|
0.58–1.08
|
0.14
|
Urban/rural
|
Metro counties
|
REF
| | |
Urban counties
|
0.87
|
0.76–1.00
|
0.05
|
Rural counties
|
1.30
|
0.95–1.79
|
0.10
|
Unknown
|
0.84
|
0.63–1.12
|
0.22
|
Charlson–Deyo score
|
0
|
REF
| | |
1
|
1.09
|
0.95–1.24
|
0.22
|
2
|
0.73
|
0.49–1.08
|
0.11
|
Grade
|
Well differentiated, differentiated, NOS
|
REF
| | |
Moderately differentiated, moderately well differentiated, intermediate differentiation
|
1.72
|
1.54–1.91
|
< 0.001
|
Poorly differentiated
|
3.76
|
3.28–4.31
|
< 0.001
|
AJCC pathologic stage
|
T1C
|
REF
| | |
T2
|
1.62
|
1.48–1.77
|
< 0.001
|
Lymphovascular invasion
|
Not present
|
REF
| | |
Present
|
1.41
|
1.25–1.59
|
< 0.001
|
Type of surgery
|
Breast conservation
|
REF
| | |
Mastectomy
|
1.35
|
1.06–1.72
|
0.02
|
Margin status
|
Negative
|
REF
| | |
Positive
|
1.15
|
0.92–1.44
|
0.23
|
Unknown
|
1.05
|
0.45–2.46
|
0.90
|
Radiation therapy
|
None
|
REF
| | |
Beam radiation
|
0.35
|
0.01–8.40
|
0.51
|
Radiation treatment volume
|
No radiation treatment
|
0.25
|
0.01–6.20
|
0.40
|
Breast or chest wall
|
REF
| | |
Breast/lymph nodes or chest wall/lymph nodes
|
1.24
|
0.96–1.61
|
0.10
|
Other
|
2.36
|
1.05–5.30
|
0.04
|
Unknown
|
1.30
|
0.56–3.04
|
0.54
|